| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Bifidobacterium adolescentis (ATCC 15704 + 120h) |
- |
- |
>70 － ? |
Pediocin PA-1  |
741 |
| Bifidobacterium adolescentis (ATCC 15704 + 120h) |
- |
- |
>200 － ? |
Mutacin B-Ny266 |
741 |
| Bifidobacterium adolescentis (ATCC 15704 + 24h) |
- |
- |
0.18 － ? |
Nisin A |
741 |
| Bifidobacterium adolescentis (ATCC 15704 + 24h) |
- |
- |
1.96 － ? |
Nisin Z |
741 |
| Bifidobacterium adolescentis (ATCC 15704 + 24h) |
- |
- |
>70 － ? |
Pediocin PA-1 |
741 |
| Bifidobacterium adolescentis (ATCC 15704 + 24h) |
- |
- |
>200 － ? |
Mutacin B-Ny266 |
741 |
| Bifidobacterium adolescentis (ATCC 15704) |
- |
- |
<0.98 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
74 |
| Bifidobacterium adolescentis (ATCC 15704) |
- |
- |
1.59 － 3.9 |
Ampicillin (Omnipen) |
741 |
| Bifidobacterium adolescentis (ATCC 15704) |
- |
- |
3.95 － ? |
Chloramphenicol (Chloromycetin) |
741 |
| Bifidobacterium adolescentis (ATCC 15704) |
- |
- |
3.95 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
741 |
| Bifidobacterium adolescentis (ATCC 15704) |
- |
- |
7.8 － 15.62 |
Cloxacillin (Tegopen, Coxapen) |
741 |
| Bifidobacterium adolescentis (ATCC 15704) |
- |
- |
15.6 － ? |
Novobiocin (Albamycin) |
741 |
| Bifidobacterium adolescentis (ATCC 15704) |
- |
- |
15.62 － ? |
Pirlimycin hydrochloride |
741 |
| Bifidobacterium adolescentis (ATCC 15704) |
- |
- |
15.62 － ? |
Rifampicin (Rifampin) |
741 |
| Bifidobacterium adolescentis (ATCC 15704) |
- |
- |
15.62 － ? |
Tetracycline hydrochloride |
741 |
| Bifidobacterium adolescentis (ATCC 15704) |
- |
- |
62.5 － 125 |
Nalidixic acid (NegGam) |
741 |
| Bifidobacterium adolescentis (ATCC 15706) |
- |
- |
32 － ? |
Metronidazole (Flagyl) |
105 |